| Literature DB >> 29875337 |
Yanyan Zhang1,2,3, Yinli Li4, Suyun Li5,6,7, Hua Zhang8,9,10, Haile Ma11.
Abstract
Ultrasound treatment can improve enzymolysis efficiency by changing the amounts of sulfhydryl groups (SH) and disulfide bonds (SS) in protein. This paper proposes an in-situ and real-time monitoring method for SH and SS during ultrasound application processes using a miniature near-infrared (NIR) optical fiber spectrometer and a chemometrics model to determine the endpoint of ultrasonic treatment. The results show that SH and SS contents fluctuated greatly with the extension of ultrasonic time. The optimal spectral intervals for SH content were 869⁻947, 1207⁻1284, 1458⁻1536 and 2205⁻2274 nm, the optimal spectral intervals of SS content were 933⁻992, 1388⁻1446, 2091⁻2148 and 2217⁻2274 nm. According to the optimal spectral intervals, the synergy interval partial least squares (Si-PLS) and error back propagation neural network (BP-ANN) for SH, SS contents were established. The BP-ANN model was better than the Si-PLS model. The correlation coefficient of the prediction set (Rp) and the root mean square error of prediction (RMSEP) for the BP-ANN model of SH were 0.9113 and 0.38 μmol/g, respectively, the Rp² and residual prediction deviation of SH were 0.8305 and 2.91, respectively. For the BP-ANN model of SS, the Rp and the RMSEP were 0.7523 and 6.56 μmol/g, respectively. The Rp² and residual prediction deviation (RPD) of SS were 0.8305 and 2.91, respectively. However, the Rp² and RPD of SS was 0.5660 and 1.64, respectively. This work demonstrated that the miniature NIR combined with BP-ANN algorithms has high potential for in-situ monitoring of SH during the ultrasonic treatment process, while the spectral prediction model of SS needs to be further developed.Entities:
Keywords: disulfide bonds; in-situ monitoring; sulfhydryl groups; ultrasonic treatment; wheat gluten
Mesh:
Substances:
Year: 2018 PMID: 29875337 PMCID: PMC6100594 DOI: 10.3390/molecules23061376
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The changes of SH and SS contents during ultrasound pretreatment process. (a) SH content; (b) SS content.
Results of selected optimal spectral subintervals for prediction of SH and SS in in the ultrasound treatment process.
| Parameters | Number of Subintervals | Selected Subintervals |
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| SH (μmol/g) | 15 | [4, 5, 6, 14] | 10 | 0.9302 | 0.39 | 0.7930 | 0.76 |
| 16 | [4, 5, 13, 15] | 9 | 0.9325 | 0.38 | 0.7162 | 0.94 | |
| 17 | [1, 4, 7] | 4 | 0.9226 | 0.40 | 0.8514 | 0.58 | |
| 18 | [1, 4, 11] | 5 | 0.9200 | 0.41 | 0.8662 | 0.57 | |
| 19 | [1, 3, 5] | 5 | 0.9192 | 0.41 | 0.8188 | 0.63 | |
| 20 | [1, 5, 8, 17] | 10 | 0.9405 | 0.36 | 0.8488 | 0.64 | |
| 21 | [4, 5, 13] | 6 | 0.9348 | 0.37 | 0.8930 | 0.53 | |
| 22 | [4, 9, 19] | 10 | 0.9334 | 0.38 | 0.7773 | 0.91 | |
| 23 | [5, 7, 18, 21] | 10 | 0.9381 | 0.37 | 0.7410 | 0.95 | |
| 24 | [2, 6, 9] | 8 | 0.9344 | 0.37 | 0.8021 | 0.66 | |
| 25 | [2, 4, 6, 7] | 7 | 0.9331 | 0.37 | 0.8441 | 0.60 | |
| 26 | [2, 4, 8, 23] | 10 | 0.9512 | 0.32 | 0.7423 | 0.93 | |
| 27 | [2, 4, 8, 24] | 10 | 0.9512 | 0.33 | 0.7423 | 0.93 | |
| 28 | [2, 5, 10, 25] | 10 | 0.9366 | 0.37 | 0.8122 | 0.76 | |
| 29 | [2, 5, 7] | 9 | 0.9380 | 0.36 | 0.8126 | 0.66 | |
| 30 | [2, 6, 11, 25] | 10 | 0.9447 | 0.35 | 0.7615 | 0.93 | |
| SS (μmol/g) | 15 | [1, 3, 8, 10] | 9 | 0.6298 | 8.28 | 0.6236 | 7.40 |
| 16 | [2, 3, 6, 7] | 6 | 0.6087 | 8.17 | 0.4910 | 8.17 | |
| 17 | [9, 10, 11, 16] | 2 | 0.5667 | 7.52 | 0.6756 | 9.16 | |
| 18 | [14, 17, 18] | 7 | 0.6153 | 7.40 | 0.5898 | 9.47 | |
| 19 | [4, 10, 22, 27] | 10 | 0.8056 | 5.52 | 0.5266 | 12.10 | |
| 20 | [1, 2, 5] | 5 | 0.5571 | 8.25 | 0.4175 | 8.53 | |
| 21 | [7, 14, 18] | 7 | 0.6481 | 6.99 | 0.4884 | 10.60 | |
| 22 | [9, 10, 20] | 2 | 0.5833 | 7.40 | 0.6731 | 7.95 | |
| 23 | [8, 17, 18, 21] | 10 | 0.7238 | 6.38 | 0.4840 | 11.40 | |
| 24 | [8, 10, 11, 20] | 10 | 0.4842 | 9.56 | 0.5399 | 9.33 | |
| 25 | [8, 15, 18] | 8 | 0.6665 | 6.83 | 0.3248 | 12.60 | |
| 26 | [2, 9, 20, 22] | 10 | 0.7045 | 6.54 | 0.5664 | 9.91 | |
| 27 | [2, 7, 24] | 8 | 0.6952 | 6.63 | 0.5358 | 9.53 | |
| 28 | [2, 14, 7, 26] | 9 | 0.6505 | 7.01 | 0.6660 | 7.90 | |
| 29 | [10, 17, 27] | 7 | 0.6683 | 6.72 | 0.6123 | 8.30 | |
| 30 | [10, 17, 28] | 7 | 0.6489 | 6.91 | 0.6186 | 8.25 |
Figure 2Optimal spectral regions of SH content and SS content selected by Si-PLS (a) SH content (b) SS content.
Figure 3Reference measured versus NIR predicted value of Si-PLS model (a) SH content (b) SS content.
Figure 4RMSECV values of BP-ANN model under different PCs of SH and SS contents. (a) SH content; (b) SS content.
Figure 5Reference measured versus NIR predicted value of BP-ANN model (a) SH content (b) SS content.
Figure 6The equipment drawing of in-situ monitoring system in ultrasound treatment process.
Figure 7NIR spectra of WG during ultrasound pretreatment process. (a) Raw spectra; (b) SNV preprocessed.
Reference values for each process parameter in the calibration and prediction set.
| Parameters | Units | Subsets | S.N. a | Range | Mean | S.D. b |
|---|---|---|---|---|---|---|
| SH | μmol/g | Calibration set | 59 | 1.9508–5.4225 | 3.6189 | 1.0573 |
| Prediction set | 29 | 2.1976–5.3258 | 3.7203 | 1.1061 | ||
| SS | μmol/g | Calibration set | 59 | 34.3516–75.4038 | 51.9267 | 9.0196 |
| Prediction set | 29 | 32.2722–75.0061 | 52.4415 | 10.7267 |
a S.N., sample number. b S.D., standard deviation.